127
Views
3
CrossRef citations to date
0
Altmetric
Articles

Inhibition of Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice by a High Dietary Protein Intake

, , , , , , , , & show all
Pages 1151-1158 | Received 09 Oct 2014, Accepted 20 Jun 2015, Published online: 11 Sep 2015

REFERENCES

  • Fan ST: Hepatocellular carcinoma—resection or transplant? Nat Rev Gastroenterol Hepatol 9, 732–737, 2012. doi:10.1038/nrgastro.2012.158
  • Forner A, Llovet JM, and Bruix J: Hepatocellular carcinoma. Lancet 379, 1245–1255, 2012. doi:10.1016/S0140-6736(11)61347-0
  • Hutchinson L: Targeted therapies: doxorubicin and sorafenib improves survival in patients with advanced hepatocellular carcinoma. Nat Rev Clin Oncol 8, 61, 2011.
  • Olsen SK, Brown RS, and Siegel AB: Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies. Therap Adv Gastroenterol 3, 55–66, 2010. doi:10.1177/1756283X09346669
  • Wiseman M: The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 67, 253–256, 2008. doi:10.1017/S002966510800712X
  • Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, et al.: Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361, 1496–1501, 2003.
  • Mathers JC, Movahedi M, Macrae F, Mecklin JP, Moeslein G, et al.: Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol 13, 1242–1249, 2012. doi:10.1016/S1470-2045(12)70475-8
  • Kroenke CH, Kwan ML, Sweeney C, Castillo A, and Caan BJ: High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst 105, 616–623, 2013. doi:10.1093/jnci/djt027
  • Richman EL, Kenfield SA, Chavarro JE, Stampfer MJ, Giovannucci EL, et al.: Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality. JAMA Intern Med 173, 1318–1326, 2013. doi:10.1001/jamainternmed.2013.6536
  • Ledesma-Martinez E, Perez-Cordero C, Cordova-Galaviz Y, Sanchez-Tellez G, Huerta-Yepez S, et al.: Casein induces the proliferation of bone marrow mononuclear cells, apoptosis of WEHI-3 leukaemic cells and increased survival in a leukaemia mouse model. Oncol Lett 4, 461–466, 2012. doi:10.3892/ol.2012.758
  • Bonuccelli G, Castello-Cros R, Capozza F, Martinez-Outschoorn UE, Lin Z, et al.: The milk protein alpha-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis. Cell Cycle 11, 3972–3982, 2012. doi:10.4161/cc.22227
  • Montella M, Crispo A, and Giudice A: HCC, diet and metabolic factors: diet and HCC. Hepat Mon 11, 159–162, 2011.
  • Talamini R, Polesel J, Montella M, Dal Maso L, Crispo A, et al.: Food groups and risk of hepatocellular carcinoma: A multicenter case-control study in Italy. Int J Cancer 119, 2916–2921, 2006. doi:10.1002/ijc.22267
  • Zhang X, Zhang Q, Peng Q, Zhou J, Liao L, et al.: Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells. Biomaterials, 35, 6130–41, 2014. doi:10.1016/j.biomaterials.2014.04.037
  • Iwai S, Murai T, Makino S, Min W, Morimura K, et al.: High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice. Cancer Lett 246, 115–121, 2007. doi:10.1016/j.canlet.2006.02.008
  • Maronpot RR: Biological basis of differential susceptibility to hepatocarcinogenesis among mouse strains. J Toxicol Pathol 22, 11–33, 2009. doi:10.1293/tox.22.11
  • Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, et al.: Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 363, 2102–2113, 2010. doi:10.1056/NEJMoa1007137
  • Pasiakos SM, Cao JJ, Margolis LM, Sauter ER, Whigham LD, et al.: Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB J 27, 3837–3847, 2013. doi:10.1096/fj.13-230227
  • St Jeor ST, Howard BV, Prewitt TE, Bovee V, Bazzarre T, et al.: Dietary protein and weight reduction: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 104, 1869–1874, 2001.
  • Parker B, Noakes M, Luscombe N, and Clifton P: Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care 25, 425–430, 2002.
  • Toscani MK, Mario FM, Radavelli-Bagatini S, Wiltgen D, Matos MC, et al.: Effect of high-protein or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in southern Brazilian women with polycystic ovary syndrome: a randomized study. Gynecol Endocrinol 27, 925–930, 2011. doi:10.3109/09513590.2011.564686
  • Delimaris I: Adverse effects associated with protein intake above the recommended dietary allowance for adults. ISRN Nutr 2013, 126929, 2013. doi:10.5402/2013/126929
  • Kerstetter JE, O'Brien KO, and Insogna KL: Dietary protein, calcium metabolism, and skeletal homeostasis revisited. Am J Clin Nutr 78, 584S–592S, 2003.
  • Russell WR, Gratz SW, Duncan SH, Holtrop G, Ince J, et al.: High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 93, 1062–1072, 2011. doi:10.3945/ajcn.110.002188
  • Engberink MF, Geleijnse JM, Bakker SJ, Larsen TM, Handjieva-Darlesnka T, et al.: Effect of a high-protein diet on maintenance of blood pressure levels achieved after initial weight loss: the DiOGenes randomized study. J Hum Hypertens 29, 58–63, 2015. doi:10.1038/jhh.2014.30
  • Li Z, Tseng CH, Li Q, Deng ML, Wang M, et al.: Clinical efficacy of a medically supervised outpatient high-protein, low-calorie diet program is equivalent in prediabetic, diabetic and normoglycemic obese patients. Nutr Diabetes 4, e105, 2014. doi:10.1038/nutd.2014.1
  • Manci EA, Hyacinth HI, Capers PL, Archer DR, Pitts S, et al.: High protein diet attenuates histopathologic organ damage and vascular leakage in transgenic murine model of sickle cell anemia. Exp Biol Med (Maywood) 239, 966–974, 2014. doi: 10.1177/1535370214531863
  • Schneider C, Teufel A, Yevsa T, Staib F, Hohmeyer A, et al.: Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. Gut 61, 1733–1743, 2012. doi:10.1136/gutjnl-2011-301116
  • Archer DR, Stiles JK, Newman GW, Quarshie A, Hsu LL, et al.: C-reactive protein and interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet. J Nutr 138, 1148–1152, 2008
  • Acharya C, Cline RA, Jaligama D, Noel P, Delany JP, et al.: Fibrosis reduces severity of acute-on-chronic pancreatitis in humans. Gastroenterology 145, 466–475, 2013. doi:10.1053/j.gastro.2013.05.012
  • Bourbonnais E, Raymond VA, Ethier C, Nguyen BN, El-Leil MS, et al.: Liver fibrosis protects mice from acute hepatocellular injury. Gastroenterology 142, 130–139 e4, 2012. doi:10.1053/j.gastro.2011.09.033
  • Zhang DY, and Friedman SL: Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology 56, 769–775, 2012. doi:10.1002/hep.25670

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.